Enzymotec Ltd has signed a long term contract to supply its Krill Oil to Lupin Limited, one of the biggest pharmaceutical companies in India.
"Both companies strongly believe that the Indian market holds a huge potential for Krill oil," said Mr. Boaz Noy, senior VP at Enzymotec.
The Krill Oil + product, which will be launched on the Indian market later this year is a step in Enzymotec’s move into the expanding Asia-Pacific market.
"The deal is part of Enzymotec strategic penetration to the Asian markets. This launch will be followed by many more" said Mr. Gil Kristovsky, Enzymotec's business unit manager